Outcome of Patients With Type 1 or 2 Autoimmune Pancreatitis View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2010-08-24

AUTHORS

Frédérique Maire, Yann Le Baleur, Vinciane Rebours, Marie Pierre Vullierme, Anne Couvelard, Hélène Voitot, Alain Sauvanet, Olivia Hentic, Philippe Lévy, Philippe Ruszniewski, Pascal Hammel

ABSTRACT

OBJECTIVES: Autoimmune pancreatitis (AIP) is better described than before, but there is still no international consensus for definition, diagnosis, and treatment. Our aims were to analyze the short- and long-term outcome of patients with focus on pancreatic endocrine and exocrine functions, to search for predictive factors of relapse and pancreatic insufficiency, and to compare patients with type 1 and type 2 AIP. METHODS: All consecutive patients followed up for AIP in our center between 1999 and 2008 were included. Two groups were defined: (a) patients with type 1 AIP meeting HISORt (Histology, Imaging, Serology, Other organ involvement, and Response to steroids) criteria; (b) patients with definitive/probable type 2 AIP including those with histologically confirmed idiopathic duct-centric pancreatitis ("definitive") or suggestive imaging, normal serum IgG4, and response to steroids ("probable"). AIP-related events and pancreatic exocrine/endocrine insufficiency were looked for during follow-up. Predictive factors of relapse and pancreatic insufficiency were analyzed. RESULTS: A total of 44 patients (22 males), median age 37.5 (19-73) years, were included: 28 patients (64%) with type 1 AIP and 16 patients (36%) with type 2 AIP. First-line treatment consisted of steroids or pancreatic resection in 59 and 27% of the patients, respectively. Median follow-up was 41 (5-130) months. Steroids were effective in all treated patients. Relapse was observed in 12 patients (27%), after a median delay of 6 months (1-70). Four patients received azathioprine because of steroid resistance/dependence. High serum IgG4 level, pain at time of diagnosis, and other organ involvement were associated with relapse (P<0.05). At the end point, pancreatic atrophy was observed in 35% of patients. Exocrine and endocrine insufficiencies were present in 34 and 39% of the patients, respectively. At univariate analysis, no factor was associated with exocrine insufficiency, although female gender (P=0.04), increasing age (P=0.006), and type 1 AIP (P=0.001) were associated with the occurrence of diabetes. Steroid/azathioprine treatment did not prevent pancreatic insufficiency. Type 2 AIP was more frequently associated with inflammatory bowel disease than type 1 AIP (31 and 3%, respectively), but relapse rates were similar in both groups. CONCLUSIONS: Relapse occurs in 27% of AIP patients and is more frequent in patients with high serum IgG4 levels at the time of diagnosis. Pancreatic atrophy and functional insufficiency occur in more than one-third of the patients within 3 years of diagnosis. The outcome of patients with type 2 AIP, a condition often associated with inflammatory bowel disease, is not different from that of patients with type 1 AIP, except for diabetes. More... »

PAGES

151

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/ajg.2010.314

DOI

http://dx.doi.org/10.1038/ajg.2010.314

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1032980160

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/20736934


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Autoimmune Diseases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biopsy, Needle", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cohort Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Exocrine Pancreatic Insufficiency", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunoglobulin G", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunohistochemistry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kaplan-Meier Estimate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pancreatectomy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pancreatic Ducts", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pancreatic Function Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pancreatitis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prednisolone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Recurrence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Assessment", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Severity of Illness Index", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Gastroenterology and Pancreatology, Beaujon Hospital, AP-HP, Diderot-Paris VII University, Clichy, France", 
          "id": "http://www.grid.ac/institutes/grid.411599.1", 
          "name": [
            "Department of Gastroenterology and Pancreatology, Beaujon Hospital, AP-HP, Diderot-Paris VII University, Clichy, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maire", 
        "givenName": "Fr\u00e9d\u00e9rique", 
        "id": "sg:person.01351504544.65", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01351504544.65"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Gastroenterology and Pancreatology, Beaujon Hospital, AP-HP, Diderot-Paris VII University, Clichy, France", 
          "id": "http://www.grid.ac/institutes/grid.411599.1", 
          "name": [
            "Department of Gastroenterology and Pancreatology, Beaujon Hospital, AP-HP, Diderot-Paris VII University, Clichy, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Le Baleur", 
        "givenName": "Yann", 
        "id": "sg:person.01114775766.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01114775766.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Gastroenterology and Pancreatology, Beaujon Hospital, AP-HP, Diderot-Paris VII University, Clichy, France", 
          "id": "http://www.grid.ac/institutes/grid.411599.1", 
          "name": [
            "Department of Gastroenterology and Pancreatology, Beaujon Hospital, AP-HP, Diderot-Paris VII University, Clichy, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rebours", 
        "givenName": "Vinciane", 
        "id": "sg:person.01017252245.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017252245.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiology, Beaujon Hospital, Clichy, France", 
          "id": "http://www.grid.ac/institutes/grid.411599.1", 
          "name": [
            "Department of Radiology, Beaujon Hospital, Clichy, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vullierme", 
        "givenName": "Marie Pierre", 
        "id": "sg:person.01231224366.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231224366.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Beaujon Hospital, Clichy, France", 
          "id": "http://www.grid.ac/institutes/grid.411599.1", 
          "name": [
            "Department of Pathology, Beaujon Hospital, Clichy, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Couvelard", 
        "givenName": "Anne", 
        "id": "sg:person.0751137045.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751137045.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Biology, Beaujon Hospital, Clichy, France", 
          "id": "http://www.grid.ac/institutes/grid.411599.1", 
          "name": [
            "Department of Biology, Beaujon Hospital, Clichy, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Voitot", 
        "givenName": "H\u00e9l\u00e8ne", 
        "id": "sg:person.01310130627.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310130627.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Beaujon Hospital, Clichy, France", 
          "id": "http://www.grid.ac/institutes/grid.411599.1", 
          "name": [
            "Department of Surgery, Beaujon Hospital, Clichy, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sauvanet", 
        "givenName": "Alain", 
        "id": "sg:person.01201614045.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01201614045.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Gastroenterology and Pancreatology, Beaujon Hospital, AP-HP, Diderot-Paris VII University, Clichy, France", 
          "id": "http://www.grid.ac/institutes/grid.411599.1", 
          "name": [
            "Department of Gastroenterology and Pancreatology, Beaujon Hospital, AP-HP, Diderot-Paris VII University, Clichy, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hentic", 
        "givenName": "Olivia", 
        "id": "sg:person.0736275266.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0736275266.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Gastroenterology and Pancreatology, Beaujon Hospital, AP-HP, Diderot-Paris VII University, Clichy, France", 
          "id": "http://www.grid.ac/institutes/grid.411599.1", 
          "name": [
            "Department of Gastroenterology and Pancreatology, Beaujon Hospital, AP-HP, Diderot-Paris VII University, Clichy, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "L\u00e9vy", 
        "givenName": "Philippe", 
        "id": "sg:person.0740232450.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0740232450.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Gastroenterology and Pancreatology, Beaujon Hospital, AP-HP, Diderot-Paris VII University, Clichy, France", 
          "id": "http://www.grid.ac/institutes/grid.411599.1", 
          "name": [
            "Department of Gastroenterology and Pancreatology, Beaujon Hospital, AP-HP, Diderot-Paris VII University, Clichy, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ruszniewski", 
        "givenName": "Philippe", 
        "id": "sg:person.0640551545.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640551545.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Gastroenterology and Pancreatology, Beaujon Hospital, AP-HP, Diderot-Paris VII University, Clichy, France", 
          "id": "http://www.grid.ac/institutes/grid.411599.1", 
          "name": [
            "Department of Gastroenterology and Pancreatology, Beaujon Hospital, AP-HP, Diderot-Paris VII University, Clichy, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hammel", 
        "givenName": "Pascal", 
        "id": "sg:person.01355345644.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01355345644.55"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/ajg.2009.336", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036700394", 
          "https://doi.org/10.1038/ajg.2009.336"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ajg.2009.325", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006114762", 
          "https://doi.org/10.1038/ajg.2009.325"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1111/j.1572-0241.2007.01531.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027749897", 
          "https://doi.org/10.1111/j.1572-0241.2007.01531.x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00535-002-1108-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1075314630", 
          "https://doi.org/10.1007/s00535-002-1108-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00535-003-1178-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005542799", 
          "https://doi.org/10.1007/s00535-003-1178-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00296-009-0843-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017767428", 
          "https://doi.org/10.1007/s00296-009-0843-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1111/j.1572-0241.2008.01959_1.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010128041", 
          "https://doi.org/10.1111/j.1572-0241.2008.01959_1.x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1111/j.1572-0241.2005.00270.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017381662", 
          "https://doi.org/10.1111/j.1572-0241.2005.00270.x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ajg.2009.327", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039698368", 
          "https://doi.org/10.1038/ajg.2009.327"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010-08-24", 
    "datePublishedReg": "2010-08-24", 
    "description": "OBJECTIVES: Autoimmune pancreatitis (AIP) is better described than before, but there is still no international consensus for definition, diagnosis, and treatment. Our aims were to analyze the short- and long-term outcome of patients with focus on pancreatic endocrine and exocrine functions, to search for predictive factors of relapse and pancreatic insufficiency, and to compare patients with type 1 and type 2 AIP.\nMETHODS: All consecutive patients followed up for AIP in our center between 1999 and 2008 were included. Two groups were defined: (a) patients with type 1 AIP meeting HISORt (Histology, Imaging, Serology, Other organ involvement, and Response to steroids) criteria; (b) patients with definitive/probable type 2 AIP including those with histologically confirmed idiopathic duct-centric pancreatitis (\"definitive\") or suggestive imaging, normal serum IgG4, and response to steroids (\"probable\"). AIP-related events and pancreatic exocrine/endocrine insufficiency were looked for during follow-up. Predictive factors of relapse and pancreatic insufficiency were analyzed.\nRESULTS: A total of 44 patients (22 males), median age 37.5 (19-73) years, were included: 28 patients (64%) with type 1 AIP and 16 patients (36%) with type 2 AIP. First-line treatment consisted of steroids or pancreatic resection in 59 and 27% of the patients, respectively. Median follow-up was 41 (5-130) months. Steroids were effective in all treated patients. Relapse was observed in 12 patients (27%), after a median delay of 6 months (1-70). Four patients received azathioprine because of steroid resistance/dependence. High serum IgG4 level, pain at time of diagnosis, and other organ involvement were associated with relapse (P<0.05). At the end point, pancreatic atrophy was observed in 35% of patients. Exocrine and endocrine insufficiencies were present in 34 and 39% of the patients, respectively. At univariate analysis, no factor was associated with exocrine insufficiency, although female gender (P=0.04), increasing age (P=0.006), and type 1 AIP (P=0.001) were associated with the occurrence of diabetes. Steroid/azathioprine treatment did not prevent pancreatic insufficiency. Type 2 AIP was more frequently associated with inflammatory bowel disease than type 1 AIP (31 and 3%, respectively), but relapse rates were similar in both groups.\nCONCLUSIONS: Relapse occurs in 27% of AIP patients and is more frequent in patients with high serum IgG4 levels at the time of diagnosis. Pancreatic atrophy and functional insufficiency occur in more than one-third of the patients within 3 years of diagnosis. The outcome of patients with type 2 AIP, a condition often associated with inflammatory bowel disease, is not different from that of patients with type 1 AIP, except for diabetes.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/ajg.2010.314", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1019809", 
        "issn": [
          "0002-9270", 
          "1572-0241"
        ], 
        "name": "The American Journal of Gastroenterology", 
        "publisher": "Wolters Kluwer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "106"
      }
    ], 
    "keywords": [
      "type 2 autoimmune pancreatitis", 
      "type 1 autoimmune pancreatitis", 
      "high serum IgG4 levels", 
      "serum IgG4 levels", 
      "outcome of patients", 
      "autoimmune pancreatitis", 
      "time of diagnosis", 
      "inflammatory bowel disease", 
      "pancreatic insufficiency", 
      "endocrine insufficiency", 
      "IgG4 levels", 
      "bowel disease", 
      "predictive factors", 
      "pancreatic atrophy", 
      "probable type 2 AIP", 
      "exocrine/endocrine insufficiency", 
      "first-line treatment", 
      "type 1", 
      "long-term outcomes", 
      "idiopathic duct-centric pancreatitis", 
      "normal serum IgG4", 
      "age 37.5 years", 
      "year of diagnosis", 
      "occurrence of diabetes", 
      "HISORt criteria", 
      "suggestive imaging", 
      "azathioprine treatment", 
      "serum IgG4", 
      "pancreatic resection", 
      "organ involvement", 
      "relapse rate", 
      "consecutive patients", 
      "exocrine insufficiency", 
      "exocrine function", 
      "median delay", 
      "AIP patients", 
      "univariate analysis", 
      "female gender", 
      "pancreatic endocrine", 
      "relapse", 
      "patients", 
      "insufficiency", 
      "functional insufficiency", 
      "one-third", 
      "end point", 
      "pancreatitis", 
      "diagnosis", 
      "steroids", 
      "diabetes", 
      "atrophy", 
      "outcomes", 
      "international consensus", 
      "treatment", 
      "disease", 
      "months", 
      "azathioprine", 
      "resection", 
      "pain", 
      "group", 
      "IgG4", 
      "years", 
      "factors", 
      "exocrine", 
      "endocrine", 
      "age", 
      "levels", 
      "total", 
      "involvement", 
      "imaging", 
      "gender", 
      "aim", 
      "response", 
      "criteria", 
      "consensus", 
      "center", 
      "time", 
      "occurrence", 
      "rate", 
      "events", 
      "function", 
      "delay", 
      "focus", 
      "analysis", 
      "definition", 
      "conditions", 
      "point", 
      "dependence", 
      "type 1 AIP meeting HISORt (Histology, Imaging, Serology, Other organ involvement, and Response to steroids) criteria", 
      "AIP meeting HISORt (Histology, Imaging, Serology, Other organ involvement, and Response to steroids) criteria", 
      "meeting HISORt (Histology, Imaging, Serology, Other organ involvement, and Response to steroids) criteria", 
      "duct-centric pancreatitis", 
      "pancreatic exocrine/endocrine insufficiency", 
      "median age 37.5 (19-73) years", 
      "steroid resistance/dependence", 
      "resistance/dependence", 
      "Steroid/azathioprine treatment"
    ], 
    "name": "Outcome of Patients With Type 1 or 2 Autoimmune Pancreatitis", 
    "pagination": "151", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1032980160"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/ajg.2010.314"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "20736934"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/ajg.2010.314", 
      "https://app.dimensions.ai/details/publication/pub.1032980160"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-11-01T18:15", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/article/article_522.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/ajg.2010.314"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/ajg.2010.314'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/ajg.2010.314'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/ajg.2010.314'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/ajg.2010.314'


 

This table displays all metadata directly associated to this object as RDF triples.

376 TRIPLES      22 PREDICATES      157 URIs      140 LITERALS      33 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/ajg.2010.314 schema:about N04b74529b3e648b98993b45fbf01b5e8
2 N0aeca2153d504bcf824cd24f9bbf7f10
3 N0b576c5ca1c347688dbb9e1067d3ee36
4 N0d1e4b86960d493eb2280510302ba9b8
5 N1bbab47c9f6a4b35b8b512673de15589
6 N1e33b0415fec40d0a89501b6343ffcf8
7 N28074065da004e339d50f0fa8a8c2df3
8 N37a05bc0dd294e4aa9df5b80ae2eba3f
9 N3e522572ba364ff7b364739acfee3ca0
10 N46e768e1f5be461e9d19836fa8c9d155
11 N50d1f71101be4ae3b100a5c3eb9b57e1
12 N5206d17347e44bac9a4257a873eb0824
13 N5dc0c7e3cc21491aac944e272802b78b
14 N6644ecddd43c483abfd7cad3475f3e21
15 N6e50cc705ce745c6b3168f4ffe2e7921
16 N79cda74629524ea1bb80f7ec29df49a1
17 N7d111a6ba57246db96ac55663d9d520f
18 N86cde2a20936433ab512f0bd12c8d4e2
19 N8930e75aa9db4952a6d358948e6cc20e
20 N9974a0e085de4e63a5a06cb007484eb1
21 N9e48b6b0fb1043ee8a98f2dc80d223bd
22 Na695fb81a8c04749994070dc3f1c696c
23 Nb89f78be6922408a911bd6972f0dba65
24 Nbe68affb3e734cdb9e5a3ee9d280b3a6
25 Nc3fe9936876c45cfacdb00208f01d4ec
26 Nf67fbec780a04434a3947f560a3304bd
27 anzsrc-for:11
28 anzsrc-for:1103
29 schema:author Nb21624ff732c4f4c8c822af611ff3c3a
30 schema:citation sg:pub.10.1007/s00296-009-0843-5
31 sg:pub.10.1007/s00535-002-1108-1
32 sg:pub.10.1007/s00535-003-1178-8
33 sg:pub.10.1038/ajg.2009.325
34 sg:pub.10.1038/ajg.2009.327
35 sg:pub.10.1038/ajg.2009.336
36 sg:pub.10.1111/j.1572-0241.2005.00270.x
37 sg:pub.10.1111/j.1572-0241.2007.01531.x
38 sg:pub.10.1111/j.1572-0241.2008.01959_1.x
39 schema:datePublished 2010-08-24
40 schema:datePublishedReg 2010-08-24
41 schema:description OBJECTIVES: Autoimmune pancreatitis (AIP) is better described than before, but there is still no international consensus for definition, diagnosis, and treatment. Our aims were to analyze the short- and long-term outcome of patients with focus on pancreatic endocrine and exocrine functions, to search for predictive factors of relapse and pancreatic insufficiency, and to compare patients with type 1 and type 2 AIP. METHODS: All consecutive patients followed up for AIP in our center between 1999 and 2008 were included. Two groups were defined: (a) patients with type 1 AIP meeting HISORt (Histology, Imaging, Serology, Other organ involvement, and Response to steroids) criteria; (b) patients with definitive/probable type 2 AIP including those with histologically confirmed idiopathic duct-centric pancreatitis ("definitive") or suggestive imaging, normal serum IgG4, and response to steroids ("probable"). AIP-related events and pancreatic exocrine/endocrine insufficiency were looked for during follow-up. Predictive factors of relapse and pancreatic insufficiency were analyzed. RESULTS: A total of 44 patients (22 males), median age 37.5 (19-73) years, were included: 28 patients (64%) with type 1 AIP and 16 patients (36%) with type 2 AIP. First-line treatment consisted of steroids or pancreatic resection in 59 and 27% of the patients, respectively. Median follow-up was 41 (5-130) months. Steroids were effective in all treated patients. Relapse was observed in 12 patients (27%), after a median delay of 6 months (1-70). Four patients received azathioprine because of steroid resistance/dependence. High serum IgG4 level, pain at time of diagnosis, and other organ involvement were associated with relapse (P<0.05). At the end point, pancreatic atrophy was observed in 35% of patients. Exocrine and endocrine insufficiencies were present in 34 and 39% of the patients, respectively. At univariate analysis, no factor was associated with exocrine insufficiency, although female gender (P=0.04), increasing age (P=0.006), and type 1 AIP (P=0.001) were associated with the occurrence of diabetes. Steroid/azathioprine treatment did not prevent pancreatic insufficiency. Type 2 AIP was more frequently associated with inflammatory bowel disease than type 1 AIP (31 and 3%, respectively), but relapse rates were similar in both groups. CONCLUSIONS: Relapse occurs in 27% of AIP patients and is more frequent in patients with high serum IgG4 levels at the time of diagnosis. Pancreatic atrophy and functional insufficiency occur in more than one-third of the patients within 3 years of diagnosis. The outcome of patients with type 2 AIP, a condition often associated with inflammatory bowel disease, is not different from that of patients with type 1 AIP, except for diabetes.
42 schema:genre article
43 schema:inLanguage en
44 schema:isAccessibleForFree false
45 schema:isPartOf N0474f81ffe24437db374811959680cdb
46 N0d85b44b97024f04b712cde4380389cd
47 sg:journal.1019809
48 schema:keywords AIP meeting HISORt (Histology, Imaging, Serology, Other organ involvement, and Response to steroids) criteria
49 AIP patients
50 HISORt criteria
51 IgG4
52 IgG4 levels
53 Steroid/azathioprine treatment
54 age
55 age 37.5 years
56 aim
57 analysis
58 atrophy
59 autoimmune pancreatitis
60 azathioprine
61 azathioprine treatment
62 bowel disease
63 center
64 conditions
65 consecutive patients
66 consensus
67 criteria
68 definition
69 delay
70 dependence
71 diabetes
72 diagnosis
73 disease
74 duct-centric pancreatitis
75 end point
76 endocrine
77 endocrine insufficiency
78 events
79 exocrine
80 exocrine function
81 exocrine insufficiency
82 exocrine/endocrine insufficiency
83 factors
84 female gender
85 first-line treatment
86 focus
87 function
88 functional insufficiency
89 gender
90 group
91 high serum IgG4 levels
92 idiopathic duct-centric pancreatitis
93 imaging
94 inflammatory bowel disease
95 insufficiency
96 international consensus
97 involvement
98 levels
99 long-term outcomes
100 median age 37.5 (19-73) years
101 median delay
102 meeting HISORt (Histology, Imaging, Serology, Other organ involvement, and Response to steroids) criteria
103 months
104 normal serum IgG4
105 occurrence
106 occurrence of diabetes
107 one-third
108 organ involvement
109 outcome of patients
110 outcomes
111 pain
112 pancreatic atrophy
113 pancreatic endocrine
114 pancreatic exocrine/endocrine insufficiency
115 pancreatic insufficiency
116 pancreatic resection
117 pancreatitis
118 patients
119 point
120 predictive factors
121 probable type 2 AIP
122 rate
123 relapse
124 relapse rate
125 resection
126 resistance/dependence
127 response
128 serum IgG4
129 serum IgG4 levels
130 steroid resistance/dependence
131 steroids
132 suggestive imaging
133 time
134 time of diagnosis
135 total
136 treatment
137 type 1
138 type 1 AIP meeting HISORt (Histology, Imaging, Serology, Other organ involvement, and Response to steroids) criteria
139 type 1 autoimmune pancreatitis
140 type 2 autoimmune pancreatitis
141 univariate analysis
142 year of diagnosis
143 years
144 schema:name Outcome of Patients With Type 1 or 2 Autoimmune Pancreatitis
145 schema:pagination 151
146 schema:productId N2dccd90bc8814ec796893e60055f69aa
147 N729e0cecfec743e89e80d58086a0c0f5
148 Nd889b18f14c74a33b0231ed78947c415
149 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032980160
150 https://doi.org/10.1038/ajg.2010.314
151 schema:sdDatePublished 2021-11-01T18:15
152 schema:sdLicense https://scigraph.springernature.com/explorer/license/
153 schema:sdPublisher N2390fe8bf4704c849216c4c1abcc585a
154 schema:url https://doi.org/10.1038/ajg.2010.314
155 sgo:license sg:explorer/license/
156 sgo:sdDataset articles
157 rdf:type schema:ScholarlyArticle
158 N0474f81ffe24437db374811959680cdb schema:issueNumber 1
159 rdf:type schema:PublicationIssue
160 N04b74529b3e648b98993b45fbf01b5e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Male
162 rdf:type schema:DefinedTerm
163 N0aeca2153d504bcf824cd24f9bbf7f10 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Pancreatic Ducts
165 rdf:type schema:DefinedTerm
166 N0b576c5ca1c347688dbb9e1067d3ee36 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Pancreatectomy
168 rdf:type schema:DefinedTerm
169 N0d1109f36db148758417104aaa5b5351 rdf:first sg:person.0751137045.27
170 rdf:rest N27933eb715604359a24f963a865bd364
171 N0d1e4b86960d493eb2280510302ba9b8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Severity of Illness Index
173 rdf:type schema:DefinedTerm
174 N0d85b44b97024f04b712cde4380389cd schema:volumeNumber 106
175 rdf:type schema:PublicationVolume
176 N1425c464ff5646eeb82da93709cdcc03 rdf:first sg:person.0736275266.26
177 rdf:rest N37a0f62d93244ba79b383fb70a127d84
178 N1bbab47c9f6a4b35b8b512673de15589 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Cohort Studies
180 rdf:type schema:DefinedTerm
181 N1e33b0415fec40d0a89501b6343ffcf8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Young Adult
183 rdf:type schema:DefinedTerm
184 N1f614ac65c0a46968e101172e3995ca0 rdf:first sg:person.0640551545.21
185 rdf:rest Na57ffdc6687943b7a5bbe1940ab8f2ae
186 N2390fe8bf4704c849216c4c1abcc585a schema:name Springer Nature - SN SciGraph project
187 rdf:type schema:Organization
188 N27933eb715604359a24f963a865bd364 rdf:first sg:person.01310130627.51
189 rdf:rest Ne1a7f0928dba4157b8c600517116cbc2
190 N28074065da004e339d50f0fa8a8c2df3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Adult
192 rdf:type schema:DefinedTerm
193 N2dccd90bc8814ec796893e60055f69aa schema:name pubmed_id
194 schema:value 20736934
195 rdf:type schema:PropertyValue
196 N37a05bc0dd294e4aa9df5b80ae2eba3f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
197 schema:name Immunoglobulin G
198 rdf:type schema:DefinedTerm
199 N37a0f62d93244ba79b383fb70a127d84 rdf:first sg:person.0740232450.15
200 rdf:rest N1f614ac65c0a46968e101172e3995ca0
201 N3e522572ba364ff7b364739acfee3ca0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
202 schema:name Pancreatitis
203 rdf:type schema:DefinedTerm
204 N46e768e1f5be461e9d19836fa8c9d155 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
205 schema:name Treatment Outcome
206 rdf:type schema:DefinedTerm
207 N50d1f71101be4ae3b100a5c3eb9b57e1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
208 schema:name Biopsy, Needle
209 rdf:type schema:DefinedTerm
210 N5206d17347e44bac9a4257a873eb0824 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
211 schema:name Exocrine Pancreatic Insufficiency
212 rdf:type schema:DefinedTerm
213 N5dc0c7e3cc21491aac944e272802b78b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
214 schema:name Retrospective Studies
215 rdf:type schema:DefinedTerm
216 N6644ecddd43c483abfd7cad3475f3e21 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
217 schema:name Combined Modality Therapy
218 rdf:type schema:DefinedTerm
219 N6e50cc705ce745c6b3168f4ffe2e7921 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
220 schema:name Follow-Up Studies
221 rdf:type schema:DefinedTerm
222 N729e0cecfec743e89e80d58086a0c0f5 schema:name doi
223 schema:value 10.1038/ajg.2010.314
224 rdf:type schema:PropertyValue
225 N746c37231cbd4f0889ff22be0aebf751 rdf:first sg:person.01017252245.99
226 rdf:rest N85fb50e6853c49f499871133aee2ea1c
227 N79cda74629524ea1bb80f7ec29df49a1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
228 schema:name Female
229 rdf:type schema:DefinedTerm
230 N7d111a6ba57246db96ac55663d9d520f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
231 schema:name Risk Assessment
232 rdf:type schema:DefinedTerm
233 N8383dc41ab2c4b93b9e8e94565db731b rdf:first sg:person.01114775766.42
234 rdf:rest N746c37231cbd4f0889ff22be0aebf751
235 N85fb50e6853c49f499871133aee2ea1c rdf:first sg:person.01231224366.16
236 rdf:rest N0d1109f36db148758417104aaa5b5351
237 N86cde2a20936433ab512f0bd12c8d4e2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
238 schema:name Prednisolone
239 rdf:type schema:DefinedTerm
240 N8930e75aa9db4952a6d358948e6cc20e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
241 schema:name Kaplan-Meier Estimate
242 rdf:type schema:DefinedTerm
243 N9974a0e085de4e63a5a06cb007484eb1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
244 schema:name Recurrence
245 rdf:type schema:DefinedTerm
246 N9e48b6b0fb1043ee8a98f2dc80d223bd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
247 schema:name Immunohistochemistry
248 rdf:type schema:DefinedTerm
249 Na57ffdc6687943b7a5bbe1940ab8f2ae rdf:first sg:person.01355345644.55
250 rdf:rest rdf:nil
251 Na695fb81a8c04749994070dc3f1c696c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
252 schema:name Middle Aged
253 rdf:type schema:DefinedTerm
254 Nb21624ff732c4f4c8c822af611ff3c3a rdf:first sg:person.01351504544.65
255 rdf:rest N8383dc41ab2c4b93b9e8e94565db731b
256 Nb89f78be6922408a911bd6972f0dba65 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
257 schema:name Aged
258 rdf:type schema:DefinedTerm
259 Nbe68affb3e734cdb9e5a3ee9d280b3a6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
260 schema:name Pancreatic Function Tests
261 rdf:type schema:DefinedTerm
262 Nc3fe9936876c45cfacdb00208f01d4ec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
263 schema:name Autoimmune Diseases
264 rdf:type schema:DefinedTerm
265 Nd889b18f14c74a33b0231ed78947c415 schema:name dimensions_id
266 schema:value pub.1032980160
267 rdf:type schema:PropertyValue
268 Ne1a7f0928dba4157b8c600517116cbc2 rdf:first sg:person.01201614045.33
269 rdf:rest N1425c464ff5646eeb82da93709cdcc03
270 Nf67fbec780a04434a3947f560a3304bd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
271 schema:name Humans
272 rdf:type schema:DefinedTerm
273 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
274 schema:name Medical and Health Sciences
275 rdf:type schema:DefinedTerm
276 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
277 schema:name Clinical Sciences
278 rdf:type schema:DefinedTerm
279 sg:journal.1019809 schema:issn 0002-9270
280 1572-0241
281 schema:name The American Journal of Gastroenterology
282 schema:publisher Wolters Kluwer
283 rdf:type schema:Periodical
284 sg:person.01017252245.99 schema:affiliation grid-institutes:grid.411599.1
285 schema:familyName Rebours
286 schema:givenName Vinciane
287 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017252245.99
288 rdf:type schema:Person
289 sg:person.01114775766.42 schema:affiliation grid-institutes:grid.411599.1
290 schema:familyName Le Baleur
291 schema:givenName Yann
292 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01114775766.42
293 rdf:type schema:Person
294 sg:person.01201614045.33 schema:affiliation grid-institutes:grid.411599.1
295 schema:familyName Sauvanet
296 schema:givenName Alain
297 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01201614045.33
298 rdf:type schema:Person
299 sg:person.01231224366.16 schema:affiliation grid-institutes:grid.411599.1
300 schema:familyName Vullierme
301 schema:givenName Marie Pierre
302 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231224366.16
303 rdf:type schema:Person
304 sg:person.01310130627.51 schema:affiliation grid-institutes:grid.411599.1
305 schema:familyName Voitot
306 schema:givenName Hélène
307 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310130627.51
308 rdf:type schema:Person
309 sg:person.01351504544.65 schema:affiliation grid-institutes:grid.411599.1
310 schema:familyName Maire
311 schema:givenName Frédérique
312 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01351504544.65
313 rdf:type schema:Person
314 sg:person.01355345644.55 schema:affiliation grid-institutes:grid.411599.1
315 schema:familyName Hammel
316 schema:givenName Pascal
317 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01355345644.55
318 rdf:type schema:Person
319 sg:person.0640551545.21 schema:affiliation grid-institutes:grid.411599.1
320 schema:familyName Ruszniewski
321 schema:givenName Philippe
322 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640551545.21
323 rdf:type schema:Person
324 sg:person.0736275266.26 schema:affiliation grid-institutes:grid.411599.1
325 schema:familyName Hentic
326 schema:givenName Olivia
327 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0736275266.26
328 rdf:type schema:Person
329 sg:person.0740232450.15 schema:affiliation grid-institutes:grid.411599.1
330 schema:familyName Lévy
331 schema:givenName Philippe
332 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0740232450.15
333 rdf:type schema:Person
334 sg:person.0751137045.27 schema:affiliation grid-institutes:grid.411599.1
335 schema:familyName Couvelard
336 schema:givenName Anne
337 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751137045.27
338 rdf:type schema:Person
339 sg:pub.10.1007/s00296-009-0843-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017767428
340 https://doi.org/10.1007/s00296-009-0843-5
341 rdf:type schema:CreativeWork
342 sg:pub.10.1007/s00535-002-1108-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1075314630
343 https://doi.org/10.1007/s00535-002-1108-1
344 rdf:type schema:CreativeWork
345 sg:pub.10.1007/s00535-003-1178-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005542799
346 https://doi.org/10.1007/s00535-003-1178-8
347 rdf:type schema:CreativeWork
348 sg:pub.10.1038/ajg.2009.325 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006114762
349 https://doi.org/10.1038/ajg.2009.325
350 rdf:type schema:CreativeWork
351 sg:pub.10.1038/ajg.2009.327 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039698368
352 https://doi.org/10.1038/ajg.2009.327
353 rdf:type schema:CreativeWork
354 sg:pub.10.1038/ajg.2009.336 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036700394
355 https://doi.org/10.1038/ajg.2009.336
356 rdf:type schema:CreativeWork
357 sg:pub.10.1111/j.1572-0241.2005.00270.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1017381662
358 https://doi.org/10.1111/j.1572-0241.2005.00270.x
359 rdf:type schema:CreativeWork
360 sg:pub.10.1111/j.1572-0241.2007.01531.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1027749897
361 https://doi.org/10.1111/j.1572-0241.2007.01531.x
362 rdf:type schema:CreativeWork
363 sg:pub.10.1111/j.1572-0241.2008.01959_1.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1010128041
364 https://doi.org/10.1111/j.1572-0241.2008.01959_1.x
365 rdf:type schema:CreativeWork
366 grid-institutes:grid.411599.1 schema:alternateName Department of Biology, Beaujon Hospital, Clichy, France
367 Department of Gastroenterology and Pancreatology, Beaujon Hospital, AP-HP, Diderot-Paris VII University, Clichy, France
368 Department of Pathology, Beaujon Hospital, Clichy, France
369 Department of Radiology, Beaujon Hospital, Clichy, France
370 Department of Surgery, Beaujon Hospital, Clichy, France
371 schema:name Department of Biology, Beaujon Hospital, Clichy, France
372 Department of Gastroenterology and Pancreatology, Beaujon Hospital, AP-HP, Diderot-Paris VII University, Clichy, France
373 Department of Pathology, Beaujon Hospital, Clichy, France
374 Department of Radiology, Beaujon Hospital, Clichy, France
375 Department of Surgery, Beaujon Hospital, Clichy, France
376 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...